Literature DB >> 12858134

The link between glutamate and migraine.

Nabih M Ramadan1.   

Abstract

Migraine pain-relay centers, including the trigeminal ganglion, trigeminal nucleus caudalis, and thalamus, contain glutamate-positive neurons, and glutamate activates the trigeminal nucleus caudalis. Glutamate is implicated in cortical spreading depression, trigeminovascular activation, and central sensitization. Glutamate receptor-subtype antagonists are effective in preclinical models of migraine, and in the clinic. These preclinical and clinical observations argue for a strong link between migraine and the glutamatergic system, a link that is important to further characterize in an effort to better understand migraine mechanisms and deliver effective therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12858134     DOI: 10.1017/s1092852900018757

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  22 in total

Review 1.  Non-Invasive Neuromodulation for Headache Disorders.

Authors:  Shuhan Zhu; Michael J Marmura
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

Review 2.  5-HT(1F) Receptor agonists: a new treatment option for migraine attacks?

Authors:  Lars Neeb; Jannis Meents; Uwe Reuter
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

3.  New targets for migraine therapy.

Authors:  Amy R Tso; Peter J Goadsby
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

Review 4.  The Face of Chronic Migraine Which Has Started to be Clarified.

Authors:  Zeynep Aydin Özemir; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

Review 5.  Update on the Pharmacological Treatment of Chronic Migraine.

Authors:  Christina Sun-Edelstein; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 6.  Recent Advances in Pharmacotherapy for Migraine Prevention: From Pathophysiology to New Drugs.

Authors:  Jonathan Jia Yuan Ong; Diana Yi-Ting Wei; Peter J Goadsby
Journal:  Drugs       Date:  2018-03       Impact factor: 9.546

7.  Excitatory neurotransmitters in brain regions in interictal migraine patients.

Authors:  Andrew Prescot; Lino Becerra; Gautam Pendse; Shannon Tully; Eric Jensen; Richard Hargreaves; Perry Renshaw; Rami Burstein; David Borsook
Journal:  Mol Pain       Date:  2009-06-30       Impact factor: 3.395

8.  Common variants in the regulative regions of GRIA1 and GRIA3 receptor genes are associated with migraine susceptibility.

Authors:  Daniela Formicola; Andrea Aloia; Simone Sampaolo; Olimpia Farina; Daria Diodato; Lyn R Griffiths; Fernando Gianfrancesco; Giuseppe Di Iorio; Teresa Esposito
Journal:  BMC Med Genet       Date:  2010-06-25       Impact factor: 2.103

9.  Lack of association between GRIA1 polymorphisms and haplotypes with migraine without aura or response to triptans.

Authors:  Sarah Cargnin; Michele Viana; Daniela Mittino; Giorgio Bellomo; Cristina Tassorelli; Giuseppe Nappi; Pier Luigi Canonico; Salvatore Terrazzino
Journal:  Neurol Sci       Date:  2013-09-13       Impact factor: 3.307

Review 10.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.